Gaviscon Regular Strength Liquid Antacid Cool Mint — Class II drug recall D-1322-2020
Terminated recall by Glaxosmithkline Consumer Healthcare Holdings, reported 2020-06-24, distributed nationwide. Labeling: Label lacks warning - Magnesium safety warning is not present on the Gaviscon bottle label.
| Recall number | D-1322-2020 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Glaxosmithkline Consumer Healthcare Holdings, Warren, NJ, United States |
| Recall initiated | 2020-05-28 |
| Classified | 2020-06-18 |
| Reported by FDA | 2020-06-24 |
| Terminated | 2022-01-24 |
| Distributed | Nationwide (US) |
| Quantity | 119,364 bottles |
| Reason classes | labeling |
| NDC | 00135-0094, 00135-0094-41, 00135-0094-42, 00135-0095, 00135-0095-41, 00135-0574, 00135-0574-01 |
| Lot numbers | 8M17C1, 9E30C1, 9F05C1 |
| Expiration dates | 2020-11-30, 2021-04-30 |
Product
Gaviscon Regular Strength Liquid Antacid Cool Mint, 6 FL OZ (177 mL), Distributed by: GSK Consumer Healthcare Warren, NJ 07059, NDC 0135-0094-42
Reason for recall
Labeling: Label lacks warning - Magnesium safety warning is not present on the Gaviscon bottle label.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1322-2020. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.